Comparison of propofol , droperidol , and metoclopramide for prophylaxis of postoperative nausea and vomiting after <font color="red">breast_2</font> <font color="red">cancer_2</font> <font color="red">surgery_2</font> <font color="red">:_2</font> a prospective , randomized , double - blind , placebo - controlled study in <font color="red">Japanese_2</font> <font color="red">patients_2</font> <font color="red">._2</font> 
<br>
<br> BACKGROUND <font color="red">Breast_2</font> <font color="red">cancer_2</font> <font color="red">surgery_2</font> <font color="red">performed_2</font> <font color="red">with_2</font> <font color="red">the_2</font> <font color="red">patient_2</font> <font color="red">under_2</font> <font color="red">general_2</font> <font color="red">anesthesia_2</font> has been associated with a relatively high incidence of postoperative nausea and vomiting ( PONV ) . Between 60% and 80% of <font color="red">patients_2</font> <font color="red">who_2</font> <font color="red">undergo_2</font> <font color="red">mastectomy_2</font> <font color="red">(_2</font> <font color="red">with_2</font> <font color="red">axillary_2</font> <font color="red">dissection_2</font> <font color="red">)_2</font> experience PONV . We previously reported that propofol at a subhypnotic dose of 0.5 mg / kg was more effective than placebo in preventing PONV in <font color="red">women_2</font> <font color="red">who_2</font> <font color="red">undergo_2</font> <font color="red">mastectomy_2</font> <font color="red">._2</font> 
<br> OBJECTIVE The purpose of this study was to compare the efficacy of a subhypnotic dose of propofol with the conventional antiemetics droperidol and metoclopramide for the prophylaxis of PONV after <font color="red">breast_2</font> <font color="red">cancer_2</font> <font color="red">surgery_2</font> <font color="red">in_2</font> <font color="red">Japanese_2</font> <font color="red">patients_2</font> <font color="red">._2</font> 
<br> METHODS In this prospective , randomized , double - blind , placebo - controlled study , <font color="red">Japanese_2</font> <font color="red">women_2</font> <font color="red">were_1</font> <font color="red">randomized_1</font> <font color="red">to_1</font> <font color="red">1_1</font> <font color="red">of_1</font> <font color="red">4_1</font> <font color="red">groups_1</font> to receive IV administration of propofol 0.5 mg / kg , droperidol 20 microg / kg , metoclopramide 0.2 mg / kg , or placebo ( isotonic saline ) immediately after skin suture . A standard general anesthetic technique , including sevoflurane and air in oxygen , was used . All episodes of PONV during the first 24 hours after anesthesia administration were recorded by an investigator who was blinded to treatment assignment . The investigator questioned the patients as to whether they experienced extrapyramidal symptoms . To maintain the integrity of the study results , <font color="red">none_1</font> <font color="red">of_1</font> <font color="red">the_1</font> <font color="red">patients_1</font> <font color="red">received_1</font> <font color="red">preanesthetic_1</font> <font color="red">medication_1</font> <font color="red">._1</font> 
<br> RESULTS <font color="red">A_1</font> <font color="red">total_2</font> <font color="red">of_2</font> <font color="red">100_2</font> <font color="red">women_2</font> <font color="red">(_2</font> <font color="red">mean_2</font> <font color="red">[_2</font> <font color="red">SD_2</font> <font color="red">]_2</font> <font color="red">age_2</font> <font color="red">,_2</font> <font color="red">52_2</font> <font color="red">[_2</font> <font color="red">7_2</font> <font color="red">]_2</font> <font color="red">years_2</font> <font color="red">;_2</font> <font color="red">height_2</font> <font color="red">,_2</font> <font color="red">154_2</font> <font color="red">[_2</font> <font color="red">6_2</font> <font color="red">]_2</font> <font color="red">cm_2</font> <font color="red">;_2</font> <font color="red">weight_2</font> <font color="red">,_2</font> <font color="red">54_2</font> <font color="red">[_2</font> <font color="red">7_2</font> <font color="red">]_2</font> <font color="red">kg_2</font> <font color="red">)_2</font> <font color="red">were_2</font> <font color="red">included_2</font> <font color="red">in_2</font> <font color="red">the_2</font> <font color="red">study_2</font> <font color="red">._2</font> Each study group comprised 25 patients . There were no significant differences between treatment groups with regard to patient demographics , surgery type , or awakening time . The prevalences of PONV 0 to 24 hours after anesthesia were 28% with propofol ( P = 0.005 ) , 32% with droperidol ( P = 0.011 ) , and 60% with metoclopramide ( P = NS ) , compared with placebo ( 68% ) . No significant difference in the prevalence of PONV was found between patients receiving propofol and those receiving droperidol , and propofol and droperidol were associated with significantly lower prevalences of PONV compared with metoclopramide ( P = 0.022 and P = 0.043 , respectively ) . Extrapyramidal symptoms were not reported in any of the groups . 
<br> CONCLUSIONS The prevalences of PONV were not significantly different between propofol 0.5 mg / kg and droperidol 20 microg / kg 0 to 24 hours after anesthesia in this <font color="red">small_1</font> <font color="red">,_1</font> <font color="red">select_1</font> <font color="red">group_1</font> <font color="red">of_1</font> <font color="red">Japanese_2</font> <font color="red">women_2</font> <font color="red">who_2</font> <font color="red">underwent_2</font> <font color="red">breast_2</font> <font color="red">cancer_2</font> <font color="red">surgery_2</font> <font color="red">._2</font> The prevalences of PONV were significantly lower with propofol and droperidol compared with metoclopramide 0.2 mg / kg and placebo .